UPMC Division of Endocrinology and Metabolism at the American Diabetes Association 2026 Scientific Sessions
April 24, 2026
Faculty and trainees from the University of Pittsburgh and UPMC Division of Endocrinology and Metabolism will be speaking and presenting research at the American Diabetes Association 2026 Scientific Sessions, June 5 to 8 in New Orleans.
Below is a list of activities organized by presenting speaker/author. We invite you to attend our presentations and hope to connect with our colleagues and alumni at this year’s meeting.
All times listed are Central Standard Time.
Esra Karslioglu French, MD, MBA
Oral Presentation
1019-OR
Patient and Cost Outcomes of a Proactive Certified Diabetes Care and Education Specialists Program
Co-authors: M.E. Knueven, J. Kanter, T. Grumski, H. McClain, E. Beckjord
- Friday, June 5 | 1:30 to 1:45 p.m.
- Great Hall B (Level 1)
- Track: Clinical Diabetes / Therapeutics
- Topic: Health Care Delivery–Economics / Quality Improvement
Parul Katiyar, PhD
Oral Presentation
1008-OR
Endothelial Metallothionein Enables VEGF Therapy in Diabetic Ischemic Wound Healing.
Co-authors: S.S. Verma, D. Pandey, A. Sahi, C. Sen, K. Singh
- Friday, June 5 | 12:45 to 1 p.m.
- 217 (Level 2)
- Track: Acute and Chronic Complications
- Topic: Foot Care / Lower Extremities
Jiayi Zhou, MS
Oral Presentation
1118-OR
Risk Factors for 30-Year Incidence of Distal Symmetric Polyneuropathy by Glycemic Exposure Trajectories in Type 1 Diabetes
Co-authors: R.G. Miller, T. Costacou, T. Orchard
- Friday, June 5 | 5:45 to 6 p.m.
- 217 (Level 2)
- Track: Acute and Chronic Complications
- Topic: Neuropathy
Kanhaiya Singh, PhD
Oral Presentation
1157-OR
Vasculogenic Fibroblasts In Vivo and Their Significance in the Rescue of Diabetic Ischemic Tissue
Co-authors: C. Sen
- Saturday, June 6 | 2:30 to 2:45 p.m.
- 220 (Level 2)
- Track: Acute and Chronic Complications
- Topic: Foot Care / Lower Extremities
Symposium (Chair)
The Molecular Nexus: Inflammation, ECM, and Angiogenesis as Therapeutic Targets for Diabetic Foot Wounds
- Saturday, June 6 | 3:15 to 4:15 p.m.
- 220 (Level 2)
Chandan K. Sen, PhD, FNAI
Oral Presentation (Award Lecture)
3-IGA
Roger Pecoraro Award Lecture
- Saturday, June 6 | 1:30 to 2 p.m.
- 220 (Level 2)
- Track: Acute and Chronic Complications
- Topic: Foot Care / Lower Extremities
Chandan K. Sen, director, McGowan Institute for Regenerative Medicine, and Bartley Griffith Professor in Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, received the Roger Pecoraro Award from the American Diabetes Association (ADA) for his contribution in the treatment, prevention and management of diabetes-related foot complications. The award, part of the 2026 National Scientific and Health Care Achievement awards, is one of ADA’s highest honors.
Read more about Dr. Sen and his award from the University of Pittsburgh School of Medicine.
Symposium Presentation
Walking in Their Shoes: Insights from People with Diabetic Foot Ulcers
- Saturday, June 6 | 4:55 to 5:10 p.m.
- 220 (Level 2)
Alok Joglekar, PhD
Symposium Presentation
SABR Engineered Tregs for Precision Therapeutics
- Saturday, June 6 | 5:10 to 5:30 p.m.
- 245 (Level 2)
- Track: Immunology / Beta-Cell Replacement
- Topic: Immunology
Shannon Romano, MPH
Poster Presentation
2175-P
Age at Menopause Modifies the Effect of Clinical Risk Factors on Coronary Artery Disease Incidence in Women with Type 1 Diabetes
Co-authors: T. Costacou, S. El Khoudary, T. Orchard, M. Feghali, R.G. Miller
- Saturday, June 6 | 12:30 to 1:30 p.m.
- Poster Hall (Halls D–E)
Brandon Matthew Herbert, PhD, MPH
Poster Presentation
2197-P
The Impact of Lipid-Modifying Therapy on 30-Year Non-HDL Cholesterol and Cardiovascular Disease Is Similar by Sex in Type 1 Diabetes.
Co-authors: T. Costacou, S. El Khoudary, T. Orchard, R.G. Miller
- Sat, June 6 | 12:30 to 1:30 p.m.
- Poster Hall (Halls D–E)
Benjamin Panny, BS, MS
Poster Presentation
1919-P
Topological Phenotyping of Continuous Glucose Monitoring Data Identifies Saturated and Erratic Glycemic Phenotypes Missed by Standard Metrics
- Sat, June 6 | 12:30 to 1:30 p.m.
- Poster Hall (Halls D–E)
Maisa Feghali, MD
Panel Discussion
Can Early Pregnancy A1C Be Used to Predict Gestational Diabetes and Large-for-Gestational-Age Birthweight? Secondary Results from the GO MOMs Study
- Sun, June 7 | 4:42 to 4:54 p.m.
- 217 (Level 2)
- Track: Clinical Diabetes / Therapeutics
- Topic: Pregnancy
Margaret Zupa, MD, MS
Professional Interest Group Presentation
Expanding Access to Endocrinology Care for Adults with Complex Type 2 Diabetes through Telemedicine
- Sunday, June 7 | 11:35 to 11:50 a.m.
- Hall E-3 (Level 1)
- Track: Epidemiology / Genetics
- Topic: Epidemiology
Jun Huang, PhD
Late-Breaking Poster Presentation
3076-LB
Coupling Lysosomal and Mitochondrial Lipid Metabolism in Adipose Tissue Macrophages as a Therapeutic Strategy in Obesity
Co-authors: Y. Yeh, M. Khan, X. Zhang, B. Razani
- Sunday, June 7 | 12:30 to 1:30 p.m.
- Poster Hall (Halls D–E)
Yinan Jiang, PhD
Late-Breaking Poster Presentation
3116-LB
Wnt5a-Mediated Disruption of Lysosomal Function Drives β-Cell Dysfunction in Type 2 Diabetes Mellitus
- Sunday, June 7 | 12:30 to 1:30 p.m.
- Poster Hall (Halls D–E)
Mary Grace Rossillo, MD, PhD
Late-Breaking Poster Presentation
3014-LB
The Obesity-Risk Variant in CREBRF Protects against Diabetes by Enhancing First-Phase Insulin Secretion and β-Cell Compensation
Co-authors: J. Carlson, A. Pomer, S.L. Manna, R.L. Duckham, T.K. Naseri, R. Minster, D.E. Weeks, S.T. McGarvey, N. Hawley, E.E. Kershaw
- Sunday, June 7 | 12:30 to 1:30 p.m.
- Poster Hall (Halls D–E)
Poster Presentation
2672-P
Global Loss of CREBRF in Mice Results in Hyperglycemia Despite Resistance to Diet-Induced Obesity in Part Due to Reduced Functional Beta-Cell Mass
Co-authors: P.E. Mattila, Z. Ross, A. Wood, G. Schoiswohl, R. Liu, F. Shah, B. Chuan, M.K. Basantani, D. Gupta, D.E. Weeks, S.T. McGarvey, L. Heinsberg, M. Jurczak, V. Yechoor, E.E. Kershaw
- Monday, June 8 | 12:30 to 1:30 p.m.
- Poster Hall (Halls D–E)
Mitra Mosslemi, MSc
Poster Presentation
1406-P
Rate of Age-Related eGFR Decline Differs by Insulin Dose in Type 1 Diabetes
- Monday, June 8 | 12:30 to 1:30 p.m. (Central)
- Poster Hall (Halls D–E)
